Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gilead Sciences Inc GILD

Healthcare Biotechnology
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products... see more

Recent & Breaking News (NDAQ:GILD)

Secrets to Making Money in JCP, MTG, GILD and VZ

Marketwired March 26, 2013

What's Going On: Gilead Sciences, Regions Financial Corporation, Wal-Mart Stores

ACCESS Newswire March 22, 2013

The Reason It Trades, What's Moving VALE, GILD, CAH and DTV

Marketwired March 22, 2013

European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

Business Wire March 22, 2013

Perfect Trade Setups, How to Play GILD, COP, TWX and RIO

Marketwired March 21, 2013

Upcoming Results from Clinical Trials - Research Report on Gilead Sciences, Celgene Corporation, Sinovac Biotech, NPS Pharmaceuticals and ZIOPHARM Oncology

PR Newswire March 18, 2013

Were You in Early on CCL, CAT, ESRX and GILD

Marketwired March 18, 2013

Special Situation Coming Soon, a Look Inside MTG, GILD, RDN and GOOG

Marketwired March 15, 2013

A Forward Look, The Year Ahead - Research Report on Kellogg Company, General Mills, Inc., Gilead Sciences, Inc., Celgene Corporation and The Coca-Cola Company

PR Newswire March 13, 2013

Special Offer for Shareholders of GOOG, AMGN, PBR and GILD

Marketwired March 12, 2013

Strategy Behind Our Success, We Get in Early: BP, AXP, GILD and BIDU

Marketwired March 11, 2013

Gilead's Ranexa® Reduces Angina Frequency in Study of Chronic Angina Patients With Type 2 Diabetes

Business Wire March 10, 2013

The Straight Truth, Investing in VOD, KO, F and GILD

Marketwired March 8, 2013

Strategy Behind Our Success, We Get in Early: MMM, HD, DTV and GILD

Marketwired March 7, 2013

Before the Crowd, How we Found WMT, GILD, MRK and COF

Marketwired March 6, 2013

The Reason It Trades, What's Moving WFC, GILD, EMC and TJX

Marketwired March 5, 2013

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4

Business Wire March 1, 2013

Next Week's Trade Setups, What's in Store for GE, CELG, GILD and NWSA

Marketwired March 1, 2013

The Real Story Behind NEM, THC, SAN and GILD

Marketwired February 27, 2013

Gilead Sciences to Present at Two Upcoming Investor Conferences

Business Wire February 25, 2013